| In Vitro |
FLT3/CDK4-IN-1 (compound 23k) (various concentrations; 72 hours) has better cell antiproliferative activities against MV4-11and HCT-116 cells, with IC50 of 70 and 100 nM respectively[1]. FLT3/CDK4-IN-1 (12.5-200 nM; 24 hours) arrests the cell cycle in G1 phase in a concentration-dependent manner[1]. FLT3/CDK4-IN-1 (200-3200 nM; 48 hours) induces apoptosis in both MV4-11 and HCT-116 cells with concentration dependent manner, and is more capable in MV4-11 than HCT-116[1]. FLT3/CDK4-IN-1 (0-100 nM; 2hours) inhibits the phosphorylation of FLT3 at Tyr589/591 in a dose-dependent manner[1]. Cell Proliferation Assay Cell Line: MV4-11, HCT-116, MDA-MB-436[1] Concentration: Various concentrations Incubation Time: 72 hours Result: FLT3/CDK4-IN-1 had better cell antiproliferative activities against MV4-11and HCT-116 cells, with IC50 of 70 and 100 nM respectively. Cell Cycle Analysis Cell Line: MV4-11, HCT-116[1] Concentration: 12.5, 25, 50, 100 and 200 nM Incubation Time: 24 hours Result: Arrested the cell cycle in G1 phase in a concentration-dependent manner. Apoptosis Analysis Cell Line: MV4-11, HCT-116[1] Concentration: 200, 400, 800, 1600 and 3200 nM Incubation Time: 48 hours Result: Induced apoptosis in both MV4-11 and HCT-116 cells with concentration dependent manner, and was more capable in MV4-11 than HCT-116. Western Blot Analysis Cell Line: MV4-11[1] Concentration: 0, 5, 10, 20, 40, 100 nM Incubation Time: 2 hours Result: Inhibited the phosphorylation of FLT3 at Tyr589/591 in a dose-dependent manner.
|
